Shanghai Shen Lian Biomedical Corporation reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 286.58 million compared to CNY 272.42 million a year ago. Revenue was CNY 286.58 million compared to CNY 272.42 million a year ago.

Net income was CNY 72.36 million compared to CNY 91.89 million a year ago. Basic earnings per share from continuing operations was CNY 0.18 compared to CNY 0.22 a year ago. Diluted earnings per share from continuing operations was CNY 0.18 compared to CNY 0.22 a year ago.